Fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: A randomized, placebo-Controlled Trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024409

Enrollment

Unknown

Registered

2019-07-10

Start date

2018-02-01

Completion date

Unknown

Last updated

2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

small intestinal bacteria overgrowth

Interventions

FMT group:fecal microbiota transplantation

placebo group:placebo

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 10 to 80 years old; 2. Positive LHBT for SIBO.

Exclusion criteria

Exclusion criteria: 1. Those taking probiotics or antibiotics; 2. Patients who could not complete the follow-up for at least 60 days after FMT; 3. Fever; 4. Dependent tube feeding; 5. Have serious gastrointestinal problems (such as life-threatening intestinal obstruction, perforation and bleeding) that require immediate treatment; 6. Severe immunodeficiency disease; 7. Have a history of severe allergy; 8. Suffering from ulcerative colitis, Crohn's disease, celiac disease, etc.;

Design outcomes

Primary

Measure	Time frame
Gastrointestinal Symptoms Rating Scales;lactulose hydrogen breath test;	—

Countries

China

Contacts

Public ContactYanling Wei

Army Medical Center of Chinese People's Liberation Army

lingzi016@126.com+86 15310354666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 16, 2026